AXSM Logo

Axsome Therapeutics, Inc. (AXSM) 

NASDAQ$125.9
Market Cap
$6.14B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
475 of 924
Rank in Industry
280 of 527

AXSM Insider Trading Activity

AXSM Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$10,261,7528100

Related Transactions

Coleman Markdirector0$02$789,107$-789,107
Saad Mark Edirector0$01$1.01M$-1.01M
Pizzie NickChief Financial Officer0$02$1.95M$-1.95M
Jacobson Mark L.Chief Operating Officer0$03$6.52M$-6.52M

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly â€¦

Insider Activity of Axsome Therapeutics, Inc.

Over the last 12 months, insiders at Axsome Therapeutics, Inc. have bought $0 and sold $10.26M worth of Axsome Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Axsome Therapeutics, Inc. have bought $242,389 and sold $6.92M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,950 shares for transaction amount of $147,350 was made by JEFFS ROGER (director) on 2021‑11‑19.

List of Insider Buy and Sell Transactions, Axsome Therapeutics, Inc.

2025-02-14SalePizzie NickChief Financial Officer
3,000
0.0062%
$131.07$393,210-4.14%
2025-02-13SalePizzie NickChief Financial Officer
12,000
0.0244%
$129.86$1.56M-4.50%
2024-09-11SaleSaad Mark Edirector
11,016
0.0226%
$91.31$1.01M+2.92%
2024-08-09SaleJacobson Mark L.Chief Operating Officer
47,739
0.1009%
$84.26$4.02M+11.55%
2024-05-29SaleColeman Markdirector
5,248
0.011%
$75.14$394,333+19.63%
2024-05-29SaleJacobson Mark L.Chief Operating Officer
7,910
0.0165%
$74.31$587,813+19.63%
2024-05-28SaleColeman Markdirector
5,249
0.0108%
$75.21$394,775+17.18%
2024-04-01SaleJacobson Mark L.Chief Operating Officer
24,662
0.0522%
$77.24$1.9M+14.40%
2024-03-15SaleJEFFS ROGERdirector
2,347
0.0047%
$71.61$168,062+15.50%
2024-03-14SaleJEFFS ROGERdirector
16,976
0.036%
$69.70$1.18M+25.01%
2023-09-15SaleColeman Markdirector
29,588
0.0626%
$75.18$2.22M+1.06%
2021-11-19PurchaseJEFFS ROGERdirector
3,950
0.0109%
$37.30$147,350+3.44%
2021-11-18PurchaseColeman Markdirector
1,430
0.0037%
$35.09$50,181+4.03%
2021-11-18PurchasePizzie NickCHIEF FINANCIAL OFFICER
955
0.0025%
$35.26$33,676+4.03%
2021-11-17PurchaseSaad Mark Edirector
3,300
0.0087%
$34.52$113,922+7.00%
2021-05-12PurchaseColeman Markdirector
500
0.0014%
$58.15$29,075-38.38%
2020-06-29PurchaseColeman Markdirector
650
0.0018%
$78.50$51,025-5.10%
2020-06-29PurchasePizzie NickChief Financial Officer
777
0.0021%
$76.64$59,549-5.10%
2019-09-26PurchasePizzie NickChief Financial Officer
2,180
0.0063%
$24.80$54,064+210.19%
2019-06-26PurchaseColeman Markdirector
15,800
0.0481%
$23.10$364,980+145.30%
Total: 28
*Gray background shows transactions not older than one year

Insider Historical Profitability

51.12%
Pizzie NickChief Financial Officer
42187
0.0865%
$5.31M62+84.72%
Coleman Markdirector
14600
0.0299%
$1.84M73+51.01%
Saad Mark Edirector
10002
0.0205%
$1.26M21+23.86%
JEFFS ROGERdirector
120756
0.2476%
$15.2M12+3.44%
Kaye RandallChief Medical Officer
6022
0.0123%
$758,169.8010<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$159,914,414
243
18.52%
$6.12B
$211,610,344
91
38.45%
$7.52B
$52,263,649
70
1.18%
$4.87B
$108,876,545
67
72.81%
$7.92B
$42,463,802
57
17.85%
$7.76B

AXSM Institutional Investors: Active Positions

Increased Positions154+47.68%5M+13.34%
Decreased Positions136-42.11%6M-15.41%
New Positions62New2MNew
Sold Out Positions40Sold Out2MSold Out
Total Postitions341+5.57%38M-2.07%

AXSM Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Rtw Investments, Lp$493,902.008.27%4.05M-138,192-3.3%2024-12-31
Vanguard Group Inc$475,751.007.96%3.9M-92,866-2.32%2024-12-31
Blackrock, Inc.$430,756.007.21%3.53M+135,015+3.97%2024-12-31
Fairmount Funds Management Llc$179,084.003%1.47M-891,094-37.76%2024-12-31
Bvf Inc/Il$169,219.002.83%1.39M+342,064+32.7%2024-12-31
Fmr Llc$121,964.002.04%1M-87,641-8.05%2024-12-31
Ra Capital Management, L.P.$121,910.002.04%1M00%2024-12-31
Macquarie Group Ltd$117,527.001.97%964,047-31,240-3.14%2024-12-31
State Street Corp$115,479.001.93%947,251+30,443+3.32%2024-12-31
Geode Capital Management, Llc$111,248.001.86%912,538+4,079+0.45%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.71SellsBuysStrong BuyBuyHoldSellStrong SellAXSMHighAverageLowSeries 4